Clinical trial
Prospective, Non-interventional Clinical Study of Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
NCT02922257 is registered in ClinicalTrials.gov with Corcept Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Non-interventional Clinical Study of Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery
- Lead sponsor
- Corcept Therapeutics
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2016
- Completion date
- October 30, 2018
- Enrollment
- 26 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
cushing's syndrome